152 related articles for article (PubMed ID: 37522480)
21. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
22. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
23. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
Rousseau A; Van Dreden P; Khaterchi A; Larsen AK; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1793-1800. PubMed ID: 29075792
[TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
25. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
26. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD
J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268
[TBL] [Abstract][Full Text] [Related]
29. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
30. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA.
Lysov Z; Dwivedi DJ; Gould TJ; Liaw PC
Blood Coagul Fibrinolysis; 2017 Jan; 28(1):72-82. PubMed ID: 26919453
[TBL] [Abstract][Full Text] [Related]
31. Cancer microvesicles induce tissue factor-related procoagulant activity in endothelial cells in vitro.
Adesanya MA; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):365-372. PubMed ID: 27841803
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.
Tilley RE; Holscher T; Belani R; Nieva J; Mackman N
Thromb Res; 2008; 122(5):604-9. PubMed ID: 18262600
[TBL] [Abstract][Full Text] [Related]
33. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of cancer-associated thrombosis.
Tatsumi K
Int J Hematol; 2024 May; 119(5):495-504. PubMed ID: 38421488
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Geddings JE; Hisada Y; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N
J Thromb Haemost; 2016 Jan; 14(1):153-66. PubMed ID: 26516108
[TBL] [Abstract][Full Text] [Related]
36. Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester.
Olausson N; Mobarrez F; Wallen H; Westerlund E; Hovatta O; Henriksson P
Thromb Haemost; 2016 Aug; 116(3):517-23. PubMed ID: 27412479
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and risk factors of thrombosis in cancer.
Falanga A; Russo L; Milesi V; Vignoli A
Crit Rev Oncol Hematol; 2017 Oct; 118():79-83. PubMed ID: 28917273
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
Woei-A-Jin FJ; Tesselaar ME; Garcia Rodriguez P; Romijn FP; Bertina RM; Osanto S
Br J Cancer; 2016 Jul; 115(3):332-8. PubMed ID: 27404454
[TBL] [Abstract][Full Text] [Related]
40. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
